Skip to main content
SpringerLink
Log in

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Corticostriatal glutamatergic neurons impinging on the so-called “direct” striato-thalamic pathways appear to act as a driving force with respect to psychomotor functions, whereas corticostriatal glutamatergic neurons projecting to the “indirect” striato-thalamic route appear to mediate inhibition of the thalamus and thus act as a “brake” with respect to psychomotor functions. The GABAergic striatal projection neurons pertaining to the “direct” pathway mediating behavioural stimulation appear to be phasically activated, whereas GABAergic striatal projection neurons pertaining to the “indirect” pathway mediating suppression of behaviour must be assumed to display a high tonic activity. Such an organization could explain some of the behavioural differences between competitive and un-competitive NMDA antagonists, since the binding of competitive NMDA antagonists is inhibited by glutamate, whereas the binding of un-competitive NMDA antagonists is enhanced by the presence of NMDA receptor agonists, a phenomenon called use/agonist dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurol Sci 12, 366–375

    Google Scholar 

  • Albin RL, Reiner A, Anderson K, Penney JB, Young AB (1990) Striatal and nigral neuron subpopulations in rigid Huntington's disease. Implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 27: 357–365

    Google Scholar 

  • Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurol Sci 13: 266–271

    Google Scholar 

  • Alheid GF, Heimer L (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatrie disorders: the striatopallidal, amaygdaloid, and corticopetal components of substantia innominata. Neuroscience 27: 1–39

    Google Scholar 

  • Annies R, Löscher W (1992) Both non-competitive and competitive NMDA receptor antagonists increase dopamine and serotonin turnover in several brain regions of rats. Naunyn Schmiedebergs Arch Pharmacol 345 [Suppl]: R 119

    Google Scholar 

  • Bennett DA, Bernard PS, Amrick CL, Wilson DE, Liebman JM, Hutchison AJ (1989) Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 250: 454–460

    Google Scholar 

  • Boldry RC, Uretsky NJ (1988) The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens. Neuropharmacology 27: 569–577

    Google Scholar 

  • Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and biochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229: 75–82

    Google Scholar 

  • Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179–186

    Google Scholar 

  • Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. Trends Neurol Sci 13: 272–276

    Google Scholar 

  • Carlsson M, Svensson A (1990) The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA 494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci 47: 1729–1736

    Google Scholar 

  • Chevalier G, Deniau JM (1990) Disinhibition as a basic process in the expression of striatal functions. Trends Neurol Sci 13: 277–280

    Google Scholar 

  • Clineschmidt BV, Martin GE, Bunting PR, Rapp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5 H-dibenzo[a, d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2: 135–145

    Google Scholar 

  • Coté L, Crutcher MD (1991) The basal ganglia. In: Kandel ER, Schartz JH, Jessell TM (eds) Principles of neural science. Elsevier, Amsterdam, pp 647–659

    Google Scholar 

  • Cotman CW, Monaghan DT (1987) Chemistry and anatomy of excitatory amino acid systems. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 197–210

    Google Scholar 

  • Crossman AR, Mitchell IJ, Sambrook MA, Jackson A (1988) Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanism of chorea. Brain 111: 1211–1233

    Google Scholar 

  • Freund TF, Powell JF, Smith D (1984) Tyrosine-hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13: 1189–1215

    Google Scholar 

  • Galloway MP, Bencloucif S, Keegan MJ (1992) Effects of excitatory amino acid manipulation on serotonin facilitation of dopamine release in vivo microdialysis. Excitatory Amino Acids, Yosemite, California (Abstracts, p 19)

  • Grenhoff J, Tung CS, Svensson TH (1988) The excitatory amino acid antagonist kynurenate induced pace-maker-like firing of dopaminergic neurons. Acta Physiol Scand 134: 567–568

    Google Scholar 

  • Herrera-Marschitz M, Ungerstedt U (1987) The dopamine-γ aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Acta Physiol Scand 129: 371–380

    Google Scholar 

  • Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, Guix T, Ungerstedt U (1990) Regulation of cortical and striatal dopamine and acetylcholine release by glutamate mechanisms assayed in vivo with microdialysis: in situ stimulation with kainate-, quisqualate- and NMDA-receptor agonists. In: Lubec G, Rosenthal GA (eds) Amino acids: chemistry, biology and medicine. ESCOM, Science Publishers B.V., pp 599–604

  • Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166: 359–366

    Google Scholar 

  • Kemp JA, Foster AC, Wong EHF (1987) Non-competitive antagonists of excitatory amino acid receptors. Trends Neurol Sci 10: 294–298

    Google Scholar 

  • Koek W, Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioural effects. J Pharmacol Exp Ther 252: 349–357

    Google Scholar 

  • Leviel V, Gobert A, Guibert B (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39: 305–312

    Google Scholar 

  • Liebman JM, Amrick CL, Bernard PS, Pastor G, Boast CA, Bennett DA (1987) Distinctive behaviours induced in rodents by high doses of 2-amino-7-phosphonoheptanoic acid. In: Hicks TP, Lodge D, McLellan H (eds) Excitatory amino acid transmission. Alan R Liss, New York, pp 261–264

    Google Scholar 

  • Liljequist S (1991) Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice. Psychopharmacology 104: 17–21

    Google Scholar 

  • Liljequist S, Ossowska K, Grabowska-Andén, Andén N-E (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195: 55–61

    Google Scholar 

  • Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11: 81–86

    Google Scholar 

  • Löscher W, Annies R, Hönack D (1991) The N-methyl-D-aspartate antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rat. Neurosci Lett 128: 191–194

    Google Scholar 

  • Moghaddam B, Gruen RJ (1991) Do endogenous exicatory amino acid influence striatal dopamine release. Brain Res 544: 329–330

    Google Scholar 

  • Moghaddam B, Gruen RJ, Roth RH, Bunney BS, Adams RN (1990) Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies. Brain Res 518: 55–60

    Google Scholar 

  • Murphy DE, Schneider J, Boehm C, Lehmann J, Williams M (1987) Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 240: 778–784

    Google Scholar 

  • Murphy DE, Hutchison AJ, Hurt SD, Williams M, Sills MA (1988) Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonists with nanomolar affinity in rat brain. Br J Pharmacol 95: 932–938

    Google Scholar 

  • Nauta WJH (1989) Reciprocal links of the corpus striatum with the cerebral cortex and limbic system: a common substrate for movement and thought? In: Mueller J (ed) Neurology and psychiatry: a meeting of minds. Karger, Basel, pp 43–63

    Google Scholar 

  • Pawlowski L, Mathé JM, Svensson TH (1990) Phencyclidine activates rat A 10 dopamine neurons but reduces burst activity and causes regularization of firing. Acta Physiol Scand 139: 529–530

    Google Scholar 

  • Raffa RB, Ortegon ME, Robisch DM, Martin GE (1989) In vivo demonstration of the enhancement of MK-801 by L-glutamate. Life Sci 44: 1593–1599

    Google Scholar 

  • Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U (1990) Striatal dopamine and glutamate release: effects of intranigral injections of substance P. Acta Physiol Scand 140: 527–537

    Google Scholar 

  • Schmidt WJ (1986) Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90: 123–130

    Google Scholar 

  • Sesack SR, Pickel VM (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527: 266–279

    Google Scholar 

  • Svensson TH (1992) Firing pattern of midbrain dopamine neurons in vivo: pharmacological analysis. 7th International Catecholamine Symposium, Amsterdam (Abstracts, p 305)

  • Svensson A, Pileblad E, Carlsson M (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J Neural Transm [Gen Sect] 85: 117–129

    Google Scholar 

  • Svensson A, Carlsson A, Carlsson ML (1992) Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. J Neural Transm [Gen Sect] 90: 199–217

    Google Scholar 

  • Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167: 127–135

    Google Scholar 

  • Weihmuller FB, Ulas J, Nguyen L, Cotman CW, Marshall JF (1992) Elevated NMDA receptors in Parkinsonian striatum. NeuroReport 3: 977–980

    Google Scholar 

  • Willets J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonist. Trends Pharmacol Sci 11: 423–428

    Google Scholar 

  • Zhang J, Chiodo LA, Freeman AS (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590: 153–163

    Google Scholar 

Download references

Author information

Author notes

  1. M. L. Carlsson

    Present address: Department of Pharmacology, University of Göteborg, Göteborg, Sweden

Authors and Affiliations

    Authors
    1. M. L. Carlsson
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Carlsson, M.L. Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis). J. Neural Transmission 94, 1–10 (1993). https://doi.org/10.1007/BF01244978

    Download citation

    • Received:

    • Accepted:

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01244978

    Keywords

    Search

    Navigation